Search research articles
Contact Us
Filters
Showing results (951-960 of 972) with videos related to
Page
of 98
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 15, 2007
Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses
Richard P Beyer, Rebecca C Fry, Michael R Lasarev, et al.
Critical Care (London, England)
|
November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
May 8, 2020
T<sub>1</sub> mapping performance and measurement repeatability: results from the multi-national T<sub>1</sub> mapping standardization phantom program (T1MES)
Gabriella Captur, Abhiyan Bhandari, Rüdiger Brühl, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Archives of Virology
|
April 9, 2017
Taxonomy of the order Mononegavirales: update 2017
Gaya K Amarasinghe, Yīmíng Bào, Christopher F Basler, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Page
of 98
Search research articles
Search
Showing results (951-960 of 972) with videos related to
Sort By:
Page
of 98
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 15, 2007
Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses
Richard P Beyer, Rebecca C Fry, Michael R Lasarev, et al.
Critical Care (London, England)
|
November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
May 8, 2020
T<sub>1</sub> mapping performance and measurement repeatability: results from the multi-national T<sub>1</sub> mapping standardization phantom program (T1MES)
Gabriella Captur, Abhiyan Bhandari, Rüdiger Brühl, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Archives of Virology
|
April 9, 2017
Taxonomy of the order Mononegavirales: update 2017
Gaya K Amarasinghe, Yīmíng Bào, Christopher F Basler, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Page
of 98